Mycobacterium tuberculosis (MT) infection poses a significant risk in immunocompromised individuals, particularly in areas with high MT prevalence. We describe the case of a 43-year-old heart transplant recipient who developed chronic sternal wound secretion post-transplant surgery. Imaging revealed signs of inflammatory tissue suggestive of chronic osteomyelitis. Removal of the sternal wires was performed, followed by biopsy, which identified granulomatous inflammatory tissue and Langhans cells, that led to the diagnosis of MT infection later confirmed in culture results. The patient completed a 6-month tetraconjugate antituberculous therapy, resulting in successful wound healing and infection resolution. Atypical extrapulmonary MT manifestations require high clinical suspicion, especially in immunocompromised patients, to ensure timely diagnosis and treatment with favorable outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaccas.2024.103088 | DOI Listing |
Front Chem
February 2025
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia.
Introduction: Tuberculosis (TB), caused by the (M.tb), remains a serious medical concern globally. Resistant M.
View Article and Find Full Text PDFChem Biodivers
March 2025
Birla Institute of Technology and Science - Pilani Campus: Birla Institute of Technology & Science Pilani, Pharmacy, Vidya Vihar campus, Pilani, INDIA.
We designed and synthesized pyrazolyl pyrimidine containing derivatives and screened for anti-mycobacterial activity. Different spectral techniques like HRMS, 1H, and 13C NMR are deployed for the structural confirmation of the final derivatives. Final compounds were screened against the Mycobacterium tuberculosis (Mtb) H37Rv strain.
View Article and Find Full Text PDFInt J Infect Dis
March 2025
Centre for Inflammation Research and Translational Medicine, Department of Biosciences, Brunel University of London, United Kingdom. Electronic address:
Host-directed therapy could potentially revolutionise tuberculosis control, as adjunct to traditional antibiotics for the treatment of tuberculosis disease, and as a strategy to prevent disease progression following Mycobacterium tuberculosis infection. The growing type 2 diabetes pandemic is hampering tuberculosis control worldwide, as people with diabetes have an increased risk of developing tuberculosis disease as well as worse treatment outcomes. Pulmonary tuberculosis is characterised by an inflammatory response which can cause alveolar tissue destruction and cavitation, and this inflammation is exacerbated in people with tuberculosis-diabetes comorbidity.
View Article and Find Full Text PDFSTAR Protoc
March 2025
Department of Microbiology, Pediatrics, Radiology and Public Health, University of Zaragoza, Zaragoza, Spain; CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain. Electronic address:
Here, we present a protocol to perform a time-kill assay (TKA) to quantify bacterial burden at multiple time points using colony-forming units and most probable number readouts simultaneously. We describe steps for preparing inoculum, experimental conditions, and sampling bacterial counts. We then detail procedures for quantification and analysis.
View Article and Find Full Text PDFChemMedChem
March 2025
University of Kwazulu-Natal, School of Chemistry and Physics, University Road, Chiltern Hills, 4000, Durban, SOUTH AFRICA.
In this study, we designed and synthesized a new series of isoniazid-dihydropyrimidinone molecular hybrids (8a-8n). All compounds were structurally characterized using spectroscopic techniques viz., FTIR, NMR (1H, 13C, HMBC, and HSQC), and HRMS followed by their in vitro anti-tubercular evaluation including their precursors (4a-4n), and a standard anti-tubercular drug (Isoniazid; INH).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!